Abpro Holdings Soars 14.29% on Bullish Outlook, BioCelsus Partnership

On July 25, 2025, Abpro Holdings surged 14.29% in pre-market trading, marking a significant rise in its stock price.

Abpro Holdings has received positive signals from both short and long-term moving averages, indicating a bullish outlook for the stock. This technical analysis suggests that the stock is currently in a favorable position for investors.

Analysts have rated Abpro Holdings as a "Buy," with a 12-month target price of $2.00, representing a substantial upside from its current price. This rating reflects the confidence in the company's future performance and growth potential.

Abpro Holdings recently signed a consulting agreement with BioCelsus, which is expected to enhance its operational capabilities and strategic initiatives. This partnership is likely to contribute to the company's long-term success and stock performance.